Acetylation and activation of STAT3 mediated by nuclear translocation of CD44

Jia-Lin Lee1, Mei-Jung Wang, Jeou-Yuan Chen

  • 1Institute of Biomedical Sciences, Academia Sinica, Taipei 115, Taiwan, Republic of China.

Insights

Cancer stem cell marker CD44 translocates to the nucleus, reprogramming cell fate by binding promoters like cyclin D1. This novel mechanism involves CD44 complexing with STAT3 and p300 to enhance cyclin D1 expression and cell proliferation.

Area of Science:

  • Molecular Biology
  • Cell Biology
  • Cancer Research

Background:

  • CD44, a type I transmembrane glycoprotein, is a recognized marker for cancer stem cells.
  • CD44's role in cancer progression and its intracellular functions are areas of ongoing investigation.

Purpose of the Study:

  • To elucidate the novel function of CD44 in transcriptional regulation.
  • To investigate the mechanism of CD44 internalization, nuclear translocation, and its impact on gene expression.

Main Methods:

  • Utilized techniques to track CD44 internalization and nuclear localization.
  • Mapped the bipartite nuclear localization signal (NLS) in the CD44 cytoplasmic tail.
  • Investigated the interaction of CD44 with STAT3 and p300 using biochemical assays.
  • Analyzed the effect of CD44 on cyclin D1 promoter activity and gene expression.

Main Results:

  • Engaged CD44 is internalized and translocated to the nucleus.
  • Nuclear CD44 binds to promoters, including cyclin D1, mediating transcriptional reprogramming.
  • Internalized CD44 forms a complex with STAT3 and p300, inducing STAT3 acetylation and dimerization independently of external signals.
  • A bipartite NLS in CD44's cytoplasmic tail directs its nuclear translocation; a CD44(NLS) mutant retains STAT3 in the cytosol.
  • Acetylated STAT3 dimers, associated with CD44, bind the cyclin D1 promoter, increasing its expression and promoting cell proliferation.

Conclusions:

  • CD44 possesses a novel function in transcriptional modulation via nuclear translocation.
  • The CD44-STAT3-p300 complex regulates cyclin D1 expression, driving cell proliferation.
  • This pathway represents a new mechanism by which cancer stem cell markers influence tumor progression.

Related Concept Videos

The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...
Covalently Linked Protein Regulators02:04

Covalently Linked Protein Regulators

Proteins can undergo many types of post-translational modifications, often in response to changes in their environment. These modifications play an important role in the function and stability of these proteins. Covalently linked molecules include functional groups, such as methyl, acetyl, and phosphate groups, and also small proteins, such as ubiquitin. There are around 200 different types of covalent regulators that have been identified.
These groups modify specific amino acids in a protein.
TGF - β Signaling Pathway01:16

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors are of three kinds RI, RII, and RIII. The RI...
MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
Histone Modification02:32

Histone Modification

The histone proteins have a flexible N-terminal tail extending out from the nucleosome. These histone tails are often subjected to post-translational modifications such as acetylation, methylation, phosphorylation, and ubiquitination. Particular combinations of these modifications form “histone codes” that influence the chromatin folding and tissue-specific gene expression.
Acetylation
The enzyme histone acetyltransferase adds acetyl group to the histones. Another enzyme, histone deacetylase,...